HNMPA-(AM)₃ is a cell-permeable and selective insulin receptor tyrosine kinase inhibitor analog; it potently inhibits PTTH-induced ERK phosphorylation and ecdysteroid production; it effectively suppresses ecdysteroidogenesis (IC₅₀ = 14.2 μM) and insulin receptor activity (IC₅₀ = 14.2 μM in mosquitoes and 200 μM in mammals).